Item 1A. Risk Factors

There have been no material changes from the risk factors previously disclosed in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Set forth below is a summary of the shares repurchased by the Company during the three months ended March 31, 2026, and the number of shares remaining authorized for purchase by the Company:


Period	Total number of shares purchased	Average price paid per share		Total number of shares purchased as part of publicly announced plans or programs	Maximum number of shares that may yet be purchased under the plans or programs (1)



January 1-31, 2026	1,915,212	$	67.64	1,915,212	23,611,478
February 1-28, 2026	765,247	$	69.13	765,247	22,846,231
March 1-31, 2026	1,791,175	$	66.99	1,791,175	21,055,056
Total	4,471,634	$	67.63	4,471,634

(1) The Company's repurchase authorization was increased to 25,000,000 shares on January 8, 2026.

Previous: Item 4. Controls and Procedures · Next: Item 5. Other Information